Efficacy of short-course therapy with the ketolide telithromycin compared with 10 days of penicillin V for the treatment of pharyngitis/tonsillitis

Scandinavian Journal of Infectious Diseases

Volumn 33, Issue 12, 2001, Pages 883-890

  Norrby, S Ragnar ^a   Rabie, Willem J ^a   Bacart, Patrick ^a   Mueller, Otmar ^a   Leroy, Bruno ^a   Rangaraju, Manickam ^a   Butticaz Iroudayassamy, Emmanuelle ^a  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; KETOLIDE; PENICILLIN V; STREPTOCOCCUS ANTIGEN; TELITHROMYCIN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDIASIS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEMOLYTIC STREPTOCOCCUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; NAUSEA; PHARYNGITIS; RANDOMIZED CONTROLLED TRIAL; RASH; RHINITIS; SHORT COURSE THERAPY; THROAT CULTURE; TONSILLITIS; TREATMENT OUTCOME; VERTIGO; VOMITING;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; DOUBLE-BLIND METHOD; EUROPE; FEMALE; HUMANS; KETOLIDES; MACROLIDES; MALE; MIDDLE AGED; PENICILLIN V; PENICILLINS; PHARYNGITIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TONSILLITIS; TREATMENT OUTCOME;

EID: 0035701710     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540110077443     Document Type: Article

References (18)

1. Antibiotic treatment of adults with sore throat by community primary care physicians. A national survey, 1989-1999
2. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: A statement for health professionals
3. IDCP guidelines: Management of upper respiratory tract infections
4. Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis
5. Five vs ten days of penicillin V therapy for streptococcal pharyngitis
6. Penicillin V for group A streptococcal pharyngotonsillitis. A randomized trial of seven vs ten days' therapy
7. Penicillin failure in streptococcal tonsillopharyngitis: Causes and remedies
8. In vitro activities of the ketolide HMR 3647 against recent Gram-positive clinical isolates and Haemophilus influenzae
9. In vitro activity of the ketolide HMR 3647 against Streptococcus pyogenes
10. (HMR 3647) in vitro activity on 4000 strains of Streptococcus pyogenes isolated in northern Italy
11. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates
12. The novel ketolide HMR 3647 is highly active against worldwide isolates of Streptococcus pneumoniae and Streptococcus pyogenes
13. In vitro activity of ketolides telithromycin and HMR 3004 against Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility
14. Pharmacokinetics of 800 mg once-daily oral dosing of the ketolide, HMR 3647, in healthy young volunteers
15. Telithromycin (HMR 3647) penetrates rapidly into tonsillar tissue achieving high and prolonged tonsillar concentrations
16. Group A streptococci in the 1990s
17. Upper respiratory tract infections: Etiology, current treatment, and experience with fluoroquinolones